Pharmaniaga Bhd (7081) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.042x

Based on the latest financial reports, Pharmaniaga Bhd (7081) has a cash flow conversion efficiency ratio of -0.042x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM-20.78 Million ≈ $-5.22 Million USD) by net assets (RM489.50 Million ≈ $122.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Pharmaniaga Bhd for the company's overall valuation and market capitalisation.

Pharmaniaga Bhd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Pharmaniaga Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Pharmaniaga Bhd stock quote for real-time trading data and today's change.

Pharmaniaga Bhd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pharmaniaga Bhd ranked by their cash flow conversion efficiency. Review Pharmaniaga Bhd (7081) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Company Cash Flow Conversion Efficiency
Nano Dimension Ltd
F:2N5B
-0.050x
Electrovaya Inc.
TO:ELVA
0.023x
Kung Long Batteries Industrial Co Ltd
TW:1537
0.025x
High Liner Foods Incorporated
TO:HLF
-0.007x
PC1 Group JSC
VN:PC1
0.169x
Steppe Gold Ltd
TO:STGO
0.135x
Jiangsu Safety Wire Rope
SHG:603028
0.047x
ICBC Turkey Bank AS
IS:ICBCT
1.650x

Annual Cash Flow Conversion Efficiency for Pharmaniaga Bhd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Pharmaniaga Bhd from 2012 to 2025. Also see total assets of Pharmaniaga Bhd for a full breakdown of the balance sheet.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 RM459.15 Million
≈ $115.28 Million
RM-17.69 Million
≈ $-4.44 Million
-0.039x +86.82%
2024-12-31 RM-145.94 Million
≈ $-36.64 Million
RM42.67 Million
≈ $10.71 Million
-0.292x -70.67%
2023-12-31 RM-274.09 Million
≈ $-68.81 Million
RM46.95 Million
≈ $11.79 Million
-0.171x -141.92%
2022-12-31 RM-348.31 Million
≈ $-87.45 Million
RM-142.34 Million
≈ $-35.74 Million
0.409x +400.12%
2021-12-31 RM470.44 Million
≈ $118.11 Million
RM-64.06 Million
≈ $-16.08 Million
-0.136x -78.76%
2020-12-31 RM337.53 Million
≈ $84.74 Million
RM-25.71 Million
≈ $-6.45 Million
-0.076x -113.56%
2019-12-31 RM337.85 Million
≈ $84.82 Million
RM189.76 Million
≈ $47.64 Million
0.562x +449.59%
2018-12-31 RM509.34 Million
≈ $127.88 Million
RM-81.83 Million
≈ $-20.55 Million
-0.161x -135.44%
2017-12-31 RM528.05 Million
≈ $132.57 Million
RM239.41 Million
≈ $60.11 Million
0.453x +578.93%
2016-12-31 RM530.63 Million
≈ $133.22 Million
RM35.44 Million
≈ $8.90 Million
0.067x +434.25%
2015-12-31 RM560.00 Million
≈ $140.60 Million
RM7.00 Million
≈ $1.76 Million
0.013x -96.76%
2014-12-31 RM552.00 Million
≈ $138.59 Million
RM213.00 Million
≈ $53.48 Million
0.386x -23.89%
2013-12-31 RM503.00 Million
≈ $126.29 Million
RM255.00 Million
≈ $64.02 Million
0.507x +1355.27%
2012-12-31 RM488.00 Million
≈ $122.52 Million
RM17.00 Million
≈ $4.27 Million
0.035x --

About Pharmaniaga Bhd

KLSE:7081 Malaysia Medical Distribution
Market Cap
$294.68 Million
RM1.17 Billion MYR
Market Cap Rank
#15012 Global
#175 in Malaysia
Share Price
RM0.90
Change (1 day)
-2.72%
52-Week Range
RM0.23 - RM1.38
All Time High
RM1.38
About

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines… Read more